Published in Pigment Cell Res on October 01, 1999
The role of Rab27a in the regulation of melanosome distribution within retinal pigment epithelial cells. Mol Biol Cell (2004) 1.30
Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol (2007) 1.03
The unconventional myosin-VIIa associates with lysosomes. Cell Motil Cytoskeleton (2005) 1.03
Phagosome maturation during endosome interaction revealed by partial rhodopsin processing in retinal pigment epithelium. J Cell Sci (2014) 0.80
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study. Clin Ophthalmol (2016) 0.75
A standardized classification of ocular trauma. Ophthalmology (1996) 4.05
Retinal side-effects of sildenafil. Lancet (1999) 2.40
Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem (2000) 1.84
[Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. Klin Monbl Augenheilkd (2005) 1.66
A standardized classification of ocular trauma. Graefes Arch Clin Exp Ophthalmol (1996) 1.60
Prophylactically-administered rectal acetaminophen does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair. Anesth Analg (2001) 1.56
Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res (1999) 1.51
Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina (2000) 1.46
Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation (1999) 1.45
Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol (2007) 1.44
Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol (2008) 1.39
Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol (1998) 1.27
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells. Br J Ophthalmol (2006) 1.24
Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol (1993) 1.24
Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol (2000) 1.23
[Intravitreal bevacizumab for neovascular age-related macular degeneration]. Ophthalmologe (2006) 1.20
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 1.16
Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina (2000) 1.15
Oxidation causes melanin fluorescence. Invest Ophthalmol Vis Sci (2001) 1.11
Primary vitrectomy for pseudophakic retinal detachment. Br J Ophthalmol (1996) 1.10
Substratum adhesion and gliding in a diatom are mediated by extracellular proteoglycans. Planta (1997) 1.09
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment (SPR Study): design issues and implications. SPR Study report no. 1. Graefes Arch Clin Exp Ophthalmol (2001) 1.09
Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye (Lond) (2007) 1.08
Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol (2001) 1.08
Retinal detachment in eyes with congenital glaucoma. Retina (1992) 1.08
Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye (Lond) (2008) 1.07
Histopathological findings in eyes after silicone oil injection. Graefes Arch Clin Exp Ophthalmol (1986) 1.07
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res (2001) 1.06
[Ocular side effects and complications of intravitreal triamcinolone acetonide injection]. Ophthalmologe (2004) 1.05
Melanin granules of retinal pigment epithelium are connected with the lysosomal degradation pathway. Exp Eye Res (1999) 1.05
Successful long-term implantation of electrically inactive epiretinal microelectrode arrays in rabbits. Retina (1999) 1.04
Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats. Cell Transplant (2001) 1.02
Vesicle budding on Golgi membranes: regulation by G proteins and myosin motors. Biochim Biophys Acta (1998) 1.02
Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease. Br J Ophthalmol (1995) 1.02
Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol (2006) 1.02
Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place? Int Ophthalmol (1990) 1.01
The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells. Exp Eye Res (1998) 1.00
[Hyperbaric oxygen therapy in retinal artery occlusion]. Ophthalmologe (2000) 1.00
Choroidal neovascularization in retinochoroidal coloboma: thermal laser treatment achieves long-term stabilization of visual acuity. Eye (Lond) (2005) 1.00
The GRIP domain is a specific targeting sequence for a population of trans-Golgi network derived tubulo-vesicular carriers. Traffic (2001) 0.99
Evoked cortical potentials after electrical stimulation of the inner retina in rabbits. Graefes Arch Clin Exp Ophthalmol (2000) 0.98
Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol (2003) 0.98
Validity of two-dimensional data obtained with the Heidelberg Retina Tomograph as verified by direct measurements in normal optic nerve heads. Ger J Ophthalmol (1994) 0.98
Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol (1988) 0.98
Autologous platelet treatment for optic disc pit associated with persistent macular detachment. Graefes Arch Clin Exp Ophthalmol (1998) 0.98
Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy. Br J Ophthalmol (2004) 0.97
Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol (2000) 0.96
Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol (2008) 0.96
[Late complications following silicone injection. Long-term follow-up of 100 cases]. Klin Monbl Augenheilkd (1986) 0.95
Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol (2000) 0.95
Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res (1997) 0.94
GAIP, a Galphai-3-binding protein, is associated with Golgi-derived vesicles and protein trafficking. Am J Physiol (1999) 0.94
Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetry. Br J Ophthalmol (2004) 0.93
Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol (2000) 0.93
Long-term fluctuations of the normalised rim/disc area ratio quotient in normal eyes. Graefes Arch Clin Exp Ophthalmol (1999) 0.92
Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy? Exp Eye Res (1991) 0.92
Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol (1987) 0.92
The artificial iris diaphragm for vitreoretinal silicone oil surgery. Retina (1997) 0.91
Temporary vitreous gas tamponade by perfluoromethylcyclopentane. Graefes Arch Clin Exp Ophthalmol (1998) 0.89
Clinicopathological correlation in exudative age-related macular degeneration: recurrent choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2001) 0.89
[Silicone oils in retinal surgery ]. Ophthalmologe (2000) 0.88
[Injector implantation of a scleral-fixated intraocular lens]. Ophthalmologe (2006) 0.88
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefes Arch Clin Exp Ophthalmol (1993) 0.88
Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol (1992) 0.88
[Early vitrectomy with primary silicone oil injection in very severely injured eyes]. Klin Monbl Augenheilkd (1988) 0.88
The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina. Br J Ophthalmol (2009) 0.87
Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol (1999) 0.87
Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. Ger J Ophthalmol (1995) 0.87
[Contribution on the clinical aspects of the Goldenhar syndrome]. Klin Monbl Augenheilkd (1968) 0.87
[Current strategies for macular hole surgery in Germany, Austria and Switzerland]. Ophthalmologe (2006) 0.87
Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (1991) 0.86
Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro. Graefes Arch Clin Exp Ophthalmol (2001) 0.86
[Effects of fluorescein and indocyanine green angiography on subsequent dark adaptation and the electroretinogram]. Klin Monbl Augenheilkd (1996) 0.86
Oculocerebral non-Hodgkin's lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch Ophthalmol (2000) 0.86
Cellular photoablation to control postoperative fibrosis in filtration surgery: in vitro studies. Exp Eye Res (2000) 0.85
Laceration of the eye with a fishing hook. Br J Ophthalmol (1999) 0.85
Detection of mRNA for proteins involved in retinol metabolism in iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol (1999) 0.85
Pathogenesis of retinal detachment associated with morning glory disc. Int Ophthalmol (1995) 0.84
The intraocular foreign body. Principles and problems in the management of complicated cases by pars plana vitrectomy. Int Ophthalmol (1983) 0.84
Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery. Br J Ophthalmol (1999) 0.84
Subretinal injection of rod outer segments leads to an increase in the number of early-stage melanosomes in retinal pigment epithelial cells. Ophthalmic Res (2000) 0.84
[Refractive changes after Descemet membrane endothelial keratoplasty]. Ophthalmologe (2014) 0.84
Iris pigment epithelial cells of long evans rats demonstrate phagocytic activity. Exp Eye Res (1997) 0.83
Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro. Graefes Arch Clin Exp Ophthalmol (1998) 0.83
The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells. Exp Eye Res (1998) 0.83
The significance of fibronectin in vitreoretinal pathology. A critical evaluation. Graefes Arch Clin Exp Ophthalmol (1988) 0.83